Kyle Remenda

Kyle Remenda appears in our data through filings on Lexston Life Sciences Corp. shares, published by SEDI. Over a trading history stretching from 17 June 2021 to 20 May 2022, the count stands at 4 filings.

Sales make up the whole of the open-market record (2 sales, €874k). Since January 2022: no purchases and 2 sales on the market.

The record was last updated on 15 June 2022 with a transaction in Lexston Life Sciences Corp. Filings reach the SEDI feed a median of 6 days after the trade. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.